Joong Woo Leem Selected Research

Hyperalgesia

4/2019	Pain-Relieving Effects of mTOR Inhibitor in the Anterior Cingulate Cortex of Neuropathic Rats.
11/2017	Reactive oxygen species affect spinal cell type-specific synaptic plasticity in a model of neuropathic pain.
8/2007	Spinal AMPA receptor inhibition attenuates mechanical allodynia and neuronal hyperexcitability following spinal cord injury in rats.
7/2006	Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury.
4/2004	Involvement of peripherally released substance P and calcitonin gene-related peptide in mediating mechanical hyperalgesia in a traumatic neuropathy model of the rat.
1/2003	Attenuation of mechanical hyperalgesia following spinal cord injury by administration of antibodies to nerve growth factor in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joong Woo Leem Research Topics

Disease

6	Hyperalgesia 04/2019 - 01/2003
6	Spinal Cord Injuries (Spinal Cord Injury) 01/2017 - 01/2003
5	Neuralgia (Stump Neuralgia) 04/2019 - 04/2004
4	Pain (Aches) 01/2017 - 01/2003
4	Hypersensitivity (Allergy) 01/2015 - 03/2007
1	Chronic Pain 04/2019
1	Hemophilia A (Haemophilia) 01/2019
1	Substance-Related Disorders (Drug Abuse) 01/2013
1	Carcinogenesis 01/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2012
1	Neoplasms (Cancer) 03/2008
1	Peripheral Nerve Injuries 04/2004

Drug/Important Bio-Agent (IBA)

2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2017 - 01/2017
2	NeuropeptidesIBA 01/2017 - 04/2004
1	Proteins (Proteins, Gene)FDA Link 04/2019
1	Isoflurane FDA LinkGeneric 04/2019
1	TOR Serine-Threonine KinasesIBA 04/2019
1	Sirolimus (Rapamycin)FDA Link 04/2019
1	Peptide Elongation Factor 1 (EF-1)IBA 01/2019
1	Factor VIII (Coagulation Factor VIII)IBA 01/2019
1	Hydroxyl RadicalIBA 11/2017
1	Superoxides (Superoxide)IBA 11/2017
1	Ion Channels (Ion Channel)IBA 01/2017
1	CytokinesIBA 01/2017
1	Glutamic Acid (Glutamate)FDA Link 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 01/2015
1	gamma-Aminobutyric Acid (GABA)IBA 01/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2015
1	Kainic Acid Receptors (Kainate Receptor)IBA 01/2015
1	polysialyl neural cell adhesion moleculeIBA 01/2012
1	Pharmaceutical PreparationsIBA 01/2012
1	Excitatory Amino Acid AntagonistsIBA 07/2010
1	Ionotropic Glutamate ReceptorsIBA 07/2010
1	AMPA Receptors (AMPA Receptor)IBA 08/2007
1	2,3- dioxo- 6- nitro- 7- sulfamoylbenzo(f)quinoxaline (NBQX)IBA 08/2007
1	Capsaicin (Zostrix)FDA Link 03/2007
1	BicucullineIBA 07/2006
1	MuscimolIBA 07/2006
1	GABA Receptors (GABA Receptor)IBA 07/2006
1	phaclofenIBA 07/2006
1	Baclofen FDA LinkGeneric 07/2006
1	Calcitonin Gene-Related PeptideIBA 04/2004
1	Substance PIBA 04/2004
1	AntibodiesIBA 01/2003
1	Analgesics (Analgesic Drugs)IBA 01/2003
1	Nerve Growth Factor (NGF)IBA 01/2003

Therapy/Procedure

2	Ligation 11/2017 - 03/2007
2	Transplantation 01/2017 - 11/2010
2	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2012 - 03/2008
1	Anesthesia 04/2019
1	Injections 01/2015
1	Acupuncture Therapy 01/2013
1	Rhizotomy 03/2007